ORIC Pharmaceuticals logo
ORIC Pharmaceuticals ORIC
$ 8.17 6.24%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

ORIC Pharmaceuticals Cash Flow 2011-2024 | ORIC

Annual Cash Flow ORIC Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-85.7 M -75.1 M -59.5 M -45.3 M -23.5 M -20.7 M - - - - - - -

Depreciation & Amortization

1.03 M 966 K 897 K 970 K 1.03 M 903 K - - - - - - -

Accounts Payables

944 K 1.32 M 1.89 M 757 K - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow ORIC Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - -30.2 M - - - -20.6 M - -59.8 M -40.5 M -22.7 M - -43.3 M -31.1 M -14.9 M - -27.4 M -17.9 M -8.28 M - -16.4 M -11 M -5.53 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

- - 261 K - - - 253 K - 719 K 498 K 251 K - 668 K 451 K 229 K - 736 K 496 K 250 K - 758 K 488 K 242 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

4.25 M 2.31 M 2.99 M 944 K 3.74 M 3.19 M 1.93 M 1.32 M 1.53 M 2.09 M 888 K 1.89 M 419 K 838 K 606 K 757 K 757 K 757 K 757 K 152 K 152 K 152 K 152 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency